Identification of peptide motifs recognized by a human IgG autoanti-IgE antibody using a phage display library

Clinical and Experimental Allergy

Volumn 30, Issue 7, 2000, Pages 1041-1046

  Shakib, F ^a   Hooi, D S W ^a   Smith, S J ^a   Viciene, R Furmona ^a   Sewell, H F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anti IgE; IgE; Peptide; Phage

Indexed keywords

EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; VACCINE PRODUCTION;

AMINO ACID MOTIFS; ASTHMA; AUTOANTIBODIES; BACTERIOPHAGES; CHROMATOGRAPHY, AFFINITY; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION;

EID: 0033933355     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00852.x     Document Type: Article

References (31)

1. 1 Sutton BJ, Gould HJ. The human IgE network. Nature 1993; 366:421-8.
2. 2 Lantz CS, Yamaguchi M, Oettgen HC et al. IgE regulates mouse basophil FceRI expression in vivo. J Immunol 1997; 158:2517-21.
3. 3 Yamaguchi M, Lantz CS, Oettgen HC et al. IgE enhances mouse mast cell FceRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185:663-72.
4. 4 Presta LG, Lahr SJ, Shields RL et al: Humanization of an antibody directed against IgE. J Immunol 1993; 151:2623-32.
5. 5 Kolbinger F, Saldanha J, Hardman N, Bendig MM. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Prot Engineering 1993; 6:971-80.
6. 6 Smith SJ, Galvin A, Hall I, Shakib F. Circulating human IgG autoanti-IgE antibodies in asthma patients block the binding of IgE to its high affinity receptor. J Clin Pathol: Mol Pathol 1995; 48:148-52.
7. 7 Rudolf MP, Furukawa K, Miescher S et al. Effect of anti-IgE antibodies on FceRI-bound IgE. J Immunol 1996; 157:5646-52.
8. 8 MacGlashan DW, Bochner BS, Adelman DC et al. Down-regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158:1438-45.
9. 9 Stampfli MR, Miescher S, Aebischer I et al. Inhibition of human IgE synthesis by anti-IgE antibodies requires divalent recognition. Eur J Immunol 1994; 24:2161-7.
10. 10 Corne J, Djukanovic R, Thomas L et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety and pharmacokinetics. J Clin Invest 1997; 99:879-87.
11. 11 Fahy JV, Fleming HE, Wong HH et al. The effect of an anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-34.
12. 12 Boulet L-P, Chapman KR, Cote J et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997; 155:1835-40.
13. 13 Shakib F, Smith SJ, Pritchard DI. Do autoantibodies to IgE play a role in IgE-mediated events? Immunol Cell Biol 1995; 73:109-12.
14. 14 Marone G, Spadaro G, Palumbo C, Condorelli G. The anti-IgE/anti-FceRIα autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999; 29:17-27.
15. 15 Vogel M, Miescher S, Biaggi C, Stadler BM. Human anti-IgE antibodies by repertoire cloning. Eur J Immunol 1994; 24:1200-7.
16. 16 Shakib F, Smith SJ. In vitro basophil histamine-releasing activity of circulating IgG1 and IgG4 autoanti-IgE antibodies from asthma patients and the demonstration that anti-IgE modulates allergen-induced basophil activation. Clin Exp Allergy 1994; 24:270-5.
17. 17 Shakib F, Pritchard DI, Walsh EA et al. The detection of autoantibodies to IgE in plasma of individuals infected with hookworm (Necator americanus) and the demonstration of a predominant IgG1 anti-IgE autoantibody response. Parasite Immunol 1993; 15:47-53.
18. 18 Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990; 249:386-90.
19. 19 Greenwood J, Willis AE, Perham RN. Multiple display of foreign peptides on filamentous bacteriophage: peptides from Plasmodium falciparum circumsporozoite protein as antigens. J Mol Biol 1991; 220:821-7.
20. 20 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-7.
21. 21 Livingstone CD, Barton GJ. Identification of functional residues and secondary structure from protein multiple sequrence alignment. Meth Enzymol 1996; 266:497-512.
22. 22 Padlan EA, Davies DR. A model of the Fc immunoglobulin E. Mol Immunol 1986; 23:1063-75.
23. 23 Bernstein FC, Koetzle TF, Williams GJB et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol 1977; 112:535-42.
24. 24 Guex N, Peitch MC. SWISS-MODEL and the Swiss-Pdb viewer: an environment for comparative protein modelling. Electrophoresis 1997; 18:2714-23.
25. 25 Dorrington KJ, Bennich HH. Structure-function relationships in human immunoglobulin E. Immunol Rev 1978; 41:3-26.
26. 26 Shakib F, Powell-Richard A. Elucidation of the epitope locations of human autoanti-IgE: recognition of two epitopes located within the Ce2 and the Ce4 domains. Int Archs Allergy Appl Immunol 1991; 95:102-8.
27. 27 Henry AJ, Cook JPD, McDonnell JM et al. Participation of the N-terminal region of Ce3 in the binding of human IgE to its high-affinity receptor FceRI. Biochemistry 1997; 36:15568-78.
28. 28 Helm BA, Sayers I, Higginbottom A et al. Identification of the high affinity receptor binding region in human immunoglobulin E. J Biol Chem 1996; 271:7494-500.
29. 29 Sayers I, Cain SA, Swan JRM et al. Amino acid residues that influence FceRI-mediated effector functions of human immunoglobulin E. Biochemistry 1998; 37:16152-64.
30. 30 Pizzi E, Cortese R, Tramontano A. Mapping epitopes on protein surfaces. Biopolymers 1995; 36:675-80.
31. 31 Hellman L. Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine. Eur J Immunol 1994; 24:415-20.